arrow
K

Kim Dalhoff

university of copenhagen
H指数:37
被引数:5,128

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical relevance of pharmacogenomic information for improving prescribing practices in acutely admitted older medical patients

老年急性内科患者处方实践改善中药物基因组信息的临床相关性

2026-09-160
OAAI
Response to: comment on “A prospective pharmacokinetic study of chlordiazepoxide in patients admitted to an intensive care unit or a high dependency unit after treatment of alcohol withdrawal symptoms”

回复:关于“氯氮䓬在治疗酒精戒断症状后入住重症监护病房或高依赖病房患者中的前瞻性药代动力学研究”的评论

2026-08-070
OAAI
Central nervous system penetration of imatinib in acute lymphoblastic leukemia: Pharmacokinetic analysis and clinical implications

伊马替尼在中枢神经系统中的渗透性:急性淋巴细胞白血病的药代动力学分析及临床意义

2026-06-190
OAAI
Pharmacokinetic profiling of imatinib in relation to CYP3A4 activity in leukaemia patients

伊马替尼在白血病患者中的药代动力学特征及其与CYP3A4活性的关系

2026-05-280
OAAI
A prospective pharmacokinetic study of chlordiazepoxide in patients admitted to an intensive care unit or a high dependency unit after treatment of alcohol withdrawal symptoms

氯氮卓治疗酒精戒断症状后入住重症监护病房或高依赖病房患者的药物动力学前瞻性研究

2026-03-040
OAAI
Patients' Attitudes Towards Deprescribing and Associations With Patient-Related Factors Across Two Hospital Settings

患者对停药的态度及与两种医院环境中的患者相关因素的关联

2026-02-250
OAAI
Efficacy of an interprofessional medication review among acutely admitted older medical patients: A randomized controlled trial

不同专业间药物评审在急性入院老年内科患者中的效果:一项随机对照试验

2025-12-010
PRE
Published Population Pharmacokinetic Models of Imatinib Perform Poorly on TDM Data from Pediatric Patients

已发表的伊马替尼人群药代动力学模型在儿科患者的治疗药物监测数据上表现不佳。

2025-09-080
OAAI
Exploring the Role of Cardiac Troponin-Specific Autoantibodies: Prolonged Cardiac Troponin Elimination, Reduced Clearance, and Variable Interference across 5 Commercial Assays

探索心肌肌钙蛋白-S特异性自身抗体作用:心肌肌钙蛋白消除延长、清除率降低及在5种商业检测试剂盒中的可变干扰

2025-07-150
OAAI